Search Result "allopregnanolone"

Preclinical Analyses of the Therapeutic Potential of Allopregnanolone to Promote Neurogenesis In Vitro and In Vivo in Transgenic Mouse Model of Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 3 Issue: 1 Year: 2006 Page: 11-17
Author(s): Roberta D. Brinton, Jun M. Wang

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent

Journal: Current Alzheimer Research
Volume: 4 Issue: 5 Year: 2007 Page: 510-517
Author(s): Jun Ming Wang, Ronald W. Irwin, Lifei Liu, Shuhua Chen, Roberta Diaz Brinton

Allopregnanolone Increases the Number of Dopaminergic Neurons in Substantia Nigra of a Triple Transgenic Mouse Model of Alzheimer’s Disease

Journal: Current Alzheimer Research
Volume: 9 Issue: 4 Year: 2012 Page: 473-480
Author(s): Chenyou Sun, Xiaoming Ou, Jerry M. Farley, Craig Stockmeier, Steven Bigler, Roberta Diaz Brinton, Jun Ming Wang

Therapeutic Potential of Neurogenesis for Prevention and Recovery from Alzheimers Disease: Allopregnanolone as a Proof of Concept Neurogenic Agent

Journal: Current Alzheimer Research
Volume: 3 Issue: 3 Year: 2006 Page: 185-190
Author(s): Roberta Diaz Brinton, Jun Ming Wang

Brief but Chronic Increase in Allopregnanolone Cause Accelerated AD Pathology Differently in Two Mouse Models

Journal: Current Alzheimer Research
Volume: 10 Issue: 1 Year: 2013 Page: 38-47
Author(s): Sara K. Bengtsson,Maja Johansson,Torbjorn Backstrom,Roger M. Nitsch,Mingde Wang

Neurosteroids in the Brain Neuron: Biosynthesis, Action and Medicinal Impact on Neurodegenerative Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 73-82
Author(s): Kazuyoshi Tsutsui, Synthia H. Mellon

Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 1 Year: 2006 Page: 95-102
Author(s): X.- Y. He, S.- Y. Yang

Editorial free to download

Neurosteroids and their Therapeutic Potential: Remembering theContribution of Dr. Sabina Luchetti, Netherlands Institute forNeuroscience, Amsterdam, Netherlands

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2895-2899

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 34 Year: 2015 Page: 4972-4979
Author(s): Reymundo Lozano,Veronica Martinez-Cerdeno,Randi J. Hagerman


Neurosteroid Modulation of GABAA Receptor Function by IndependentAction at Multiple Specific Binding Sites

Journal: Current Neuropharmacology
Volume: 20 Issue: 5 Year: 2022 Page: 886-890
Author(s): Lei Wang,Douglas F. Covey,Gustav Akk,Alex S. Evers

Previous   Next

Go To   Results 1 - 1 of 143

Filter Result

Volume Year
Content Type
© 2024 Bentham Science Publishers | Privacy Policy